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The majority of sudden deaths after repair of tetralogy 
of Fallot have been presumed to be due to ventricular 
arrhythmia; however, it remains to be demonstrated 
that antiarrhythmic medication reduces the incidence of 
sudden death. Since 1978, ventricular arrhythmias have 
been treated aggressively; these include any ventricular 
arrhythmia on routine electrocardiogram and more than 
10 uniform premature ventricular complexes per hour 
on 24 hour electrocardiogram. A review was undertaken 
of 488 patients followed up for more than 1 month after 
repair of tetralogy of Fallot (mean follow-up time 6.1 
years); 13.5% had ventricular arrhythmia on routine 
electrocardiogram. Ventricular arrhythmia appeared 
from 2 months to 21 years postoperatively (mean 7.3 
years). Ventricular arrhythmias were significantly (p < 
0.01) related to: longer follow-up duration, older age at 
follow-up, older age at operation and higher postoper-
ative right ventricular systolic and end-diastolic pres-
sures. Ventricular arrhythmia on routine electrocardio-
Sudden death occurs more commonly after repair of tetral-
ogy of Fallot than in any other condition currently encoun-
tered by pediatric cardiologists (I). This problem has been 
identified for more than 10 years (2-5) and its cause has 
been the subject of much speculation. Since our observation 
in 1979 (6) that more than 30% of those with premature 
'/entricular complexes on routine electrocardiogram after 
repair of tetralogy of Fallot died suddenly, we have ag-
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gram occurred in 100% of those who later died suddenly 
compared with 12% of those who did not die (p < 0.01). 
Treatment for ventricular arrhythmia was given to 
46 patients and considered "successful" if there were 
fewer than 10 uniform premature ventricular complexes 
per hour on 24 hour electrocardiogram. A successful 
drug was found in 44 of the 46: 30 of 34 given phenytoin, 
6 of 9 given propranolol, 1 of 7 given quinidine, 1 of 2 
given disopyramide, 8 of 9 given mexiletine and 4 of 5 
given amiodarone. Sudden death did not occur in any 
of the 44 patients with successful antiarrhythmic treat-
ment compared with a 39% incidence of sudden deaths 
in those with ventricular arrhythmias who were un-
treated (7 of 21) or had unsuccessful antiarrhythmic 
treatment (2 of 2) (p < 0.01). In conclusion, with ag-
gressive antiarrhythmic treatment of ventricular ar-
rhythmias, sudden death in postoperative tetralogy of 
Fallot has been significantly reduced. 
(J Am Coil CardioI1985;6:221-7) 
gressively treated ventricular arrhythmias in these patients, 
In this report, we review the outcomes of all of our patients 
who have undergone repair of tetralogy of Fallot with spe-
cific reference to the effect of treatment of ventricular 
arrhythmias. 
Methods 
Patients. The medical records of all patients examined 
in the Section of Pediatric Cardiology, Texas Children's 
Hospital who had intracardiac repair of tetralogy of Fallot 
were reviewed, Patients were included only if a follow-up 
time of more than I month was available, All "routine" 
electrocardiograms (12 lead with rhythm strip) and 24 hour 
electrocardiograms taken more than I month after the pa-
tient's operation were reviewed for the presence and type 
of ventricular arrhythmias, as well as any conduction dis-
turbance, The time of first appearance of these abnormalities 
was recorded. The most severe ventricular arrhythmia on 
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the routine electrocardiogram or 24 hour electrocardiogram 
was also noted. 
Postoperative catheterization. Routine postoperative 
hemodynamic cardiac catheterization was recommended to 
all patients. It was performed in the postabsorptive, sedated 
state with meperidine (2 mg/kg body weight) and prometh-
azine 0 mg/kg) administered intramuscularly as premedi-
cation, with intravenous use of reduced dosages as necessary 
throughout the procedure. Right ventricular peak systolic 
and end-diastolic pressures and aortic peak systolic pressure 
were recorded as was the presence of a residual ventricular 
septal defect with a greater than 1.5: 1 ratio of pulmonary 
to systemic blood flow. Because pUlmonary artery angi-
ography was not routinely performed, pulmonary insuffi-
ciency was not evaluated. The majority of our patients re-
ceived a transanular patch during the repair of tetralogy of 
Fallot and so pulmonary insufficiency was a necessary con-
sequence. Because all right ventricular angiograms were not 
available and the written estimate of ventricular contractility 
was subjective, right ventricular systolic function was not 
assessed in this study. In any patient who underwent two 
cardiac catheterizations, the most recent data were recorded, 
unless the patient underwent a second operation. In this 
case, the postoperative data from the first operation were 
used. 
Follow-up. In addition, the age and duration from initial 
repair to the most recent follow-up were recorded. In terms 
of follow-up status, sudden death was defined as an event 
that occurred outside the hospital in a patient who was not 
acutely ill. This sudden event rendered the patient uncon-
scious and resulted in death without regain of consciousness 
(7). 
Treatment of ventricular arrhythmias. Beginning in 
1978, all patients after repair of tetralogy of Fallot were 
treated with antiarrhythmic medication if there were any 
premature ventricular complexes on routine electrocardio-
gram or more than 10 uniform premature ventricular com-
plexes in any hour (or any multiform premature ventricular 
complexes, couplets or ventricular tachycardia) on 24 hour 
electrocardiogram. Before 1978, a systematic approach to 
treatment was not used. 
Only one antiarrhythmic drug was used at a time and it 
was not used in combination with any other cardiac drug 
except digoxin or diuretic drugs, or both. For each drug, 
the dosage was increased until side effects occurred or the 
serum concentration was well above the accepted therapeu-
tic range. In general, treatment began with phenytoin (8) 
(after a loading dose, maintenance 5 to 7 mg/kg daily), and 
if this was not effective or side effects developed, recently 
mexiletine was given (9) (9 to 15 mg/kg daily). Next, if the 
right ventricular contractility was thought to be normal, 
propranolol (2 to 4 mg/kg daily) was administered. In a few 
patients, quindine (30 to 40 mg/kg daily) was administered 
(0). Finally, if all conventional agents failed, amiodarone 
(11) (after a loading dose, 5 mg/kg daily) was given. 
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Drug effectiveness was assessed by 24 hour electrocar-
diogram, obtained at least every 6 months. A drug was 
considered effective if there were no episodes of ventricular 
tachycardia, couplets or multiform premature ventricular 
complexes and there were fewer than 10 uniform premature 
ventricular complexes per hour on two consecutive 24 hour 
electrocardiograms, as well as all follow-up 24 hour elec-
trocardiograms. Treatment has been continued indefinitely 
because the ventricular arrhythmias have returned in those 
who have voluntarily stopped their medication. 
Statistical analysis. Comparison of grouped data was 
done by chi-square. Comparison of continuous data from 
two groups was done by Student's t test and comparison of 
data from three or more groups was done by analysis of 
variance with specific comparisons of two subgroups made 
after Bonferroni's modification (2). Statistical significance 
was inferred if the probability of the event occurring by 
chance was less than 0.05. 
Results 
Clinical Features 
Age at repair. The study group consisted of 488 pa-
tients, each of whom had been followed up for more than 
1 month after repair of tetralogy of Fallot. The average age 
at repair was 6.4 years (range 3 months to 36 years). In 5% 
of our patients, repair was performed before I year of age, 
in 52% before 5 years of age and in 1.7% before 20 years 
of age. 
Hemodynamics. Cardiac catheterization was performed 
in 342 (70%) of the 488 patients. The postoperative right 
ventricular systolic pressure ranged from 17 to 120 mm Hg 
(mean 48.5). In 25% of these patients, the right ventricular 
systolic pressure was 60 mm Hg or more. The right ven-
tricular end-diastolic pressure ranged from 1 to 30 mm Hg 
(mean 7.6); in 44% of the patients, it was 8 mm Hg or 
more. A residual ventricular septal defect with a pulmonary 
to systemic flow ratio greater than 1.5: 1 was present in 21 
(6.1%). 
Ventricular arrhythmias. Premature ventricular com-
plexes were noted on at least one routine electrocardiogram 
in 6703.7%) of the 488 patients; in 5801.9%) these were 
uniform and in 9 (1.8%) they were multiform. These ar-
rhythmias were first noted on the electrocardiogram between 
2 months and 21 years after repair (mean 7.3 years). In only 
18% of those with premature ventricular complexes was the 
arrhythmia noted within the first postoperative year. Pre-
mature ventricular complexes first appeared more than 10 
years postoperatively in more than one-third of the patients 
with this arrhythmia. Since each of the 488 patients under-
went a routine electrocardiogram on each clinic visit, this 
incidence of ventricular arrhythmias is not biased by selection. 
However, a 24 hour electrocardiogram was obtained in 
only 97 (20%) of the patients, and the selection of patients 
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for such a test might have been biased by the presence of 
ventricular arrhythmia on routine electrocardiogram, pal-
pitation or syncope. It is only recently that all patients have 
undergone a 24 hour electrocardiogram as part of a regular 
postoperative visit. Of the 97 patients who underwent a 24 
hour electrocardiogram, ventricular arrhythmia was found 
in 71 (73%). In 56% of these patients, there were uniform 
premature ventricular complexes, in 8% multiform com-
plexes, in 3% couplets and in 6% ventricular tachycardia. 
Drug treatment. Antiarrhythmic drugs (other than dig-
italis) were administered to 46 (10%) of the patients. An 
"effective" drug according to the previously listed criteria 
was found in 44. This control was achieved with an average 
of 1.4 drugs per patient (range 1 to 5). The average duration 
of treatment was 2.3 years (range 6 months to 6.2 years). 
Phenytoin was used most frequently and was successful 
in 88% of the patients (Table 1). In 12% of the patients, a 
generalized pruritic rash appeared within 10 days of begin-
ning treatment; therefore, the drug was discontinued. One 
patient died suddenly while supposedly on phenytoin treat-
ment. He had not undergone a 24 hour electrocardiogram 
in more than 2 years and his compliance had been ques-
tionable. Quinidine treatment was only successful in one 
the the seven patients to whom it was given, and disopyr-
amide in one of the two patients. Propranolol treatment was 
successful in six of the nine patients, including one suc-
cessfully managed through a normal pregnancy, labor and 
delivery. 
Of the investigational drugs, we gave mexiletine to nine 
patients after repair of tetralogy of Fallot, and the drug was 
successful in eight. In the remaining patient, the drug had 
to be discontinued because it caused a rash. The average 
duration of treatment with mexiletine was 1.4 years (max-
imum 2.5). We gave amiodarone to five patients and had 
success in four. The average duration was 2.6 years (max-
imum 3.5). Although the duration of therapy remains short, 
there have been no major side effects caused by amiodarone. 
Corneal microdeposits were found in two patients, and one 
had nausea that responded to a decrease in dosage. 
Conduction disturbance. The combination of complete 
right bundle branch block and left anterior hemiblock was 
found in 52 patients (10.6%). There was no statistical as-
Table 1. Treatment of Ventricular Arrhythmias in 46 
Postoperative Patients 
Drug No. of Trials* % Success Side Effects (%) 
Phenytoin 34 88 Rash (12) 
Propranolol 9 67 Lethargy (11) 
Quinidine 7 14 0 
Disopyramide 2 50 0 
Mexiletine 9 89 Nausea (22); 
rash (II) 
Amiodarone 5 80 0 
*Since patients may have received more than one drug, the total number 
of trials is greater than the total number of patients. 
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SOCIatlOn between the presence of premature ventriuclar 
complexes and right bundle branch block with left anterior 
hemiblock. There were no instances of late-appearing sec-
ond or third degree atrioventricular (A V) block on routine 
electrocardiogram. In 2 of the 97 patients who underwent 
a 24 hour electrocardiogram, short episodes of type I second 
degree A V block were noted when the patients were asleep. 
A pacemaker was implanted in eight patients. In four, 
the pacemaker was placed in the immediate postoperative 
period for surgically acquired complete A V block at the 
time of the repair. In two patients, second degree A V block 
persisted for long periods of time after the operation. A 
pacemaker was implanted in one of these two (6 months 
postoperatively) because of the electrophysiologic finding 
of Mobitz type II second degree A V block with block below 
the bundle of His on intracardiac recordings, and in the 
other (6 years postoperatively) because of reduced exercise 
tolerance associated with a slow ventricular rate. In the two 
remaining patients, a pacemaker was implanted for sinus 
bradycardia, one had reduced exercise tolerance and one 
had coexistent atrial flutter and developed profound brady-
cardia after quinidine was administered for control of his 
tachyarrhythmia. 
Follow-up. On follow-up study, 475 patients (97%) were 
alive. Sudden death had occurred in nine (1.8%) and four 
patients died nonsuddenly from cardiac causes (congestive 
heart failure in two, bacterial endocarditis in one and one 
during reoperation). The sudden deaths occurred at an av-
erage age of 16.5 years (range 5 to 25). This was from 6 
months to 16 years postoperatively (mean 5.9 years). The 
remaining 475 patients were last seen at an average age of 
12.4 years (range 9 months to 38 years). This was an average 
of 6.1 years postoperatively (range 2 months to 23 years). 
Follow-up data within the last 5 years were available for 
248 (52%) of the patients. 
Factors predisposing to ventricular arrhythmias. 
Hemodynamics. Because of the possible bias introduced by 
selection of patients for 24 hour electrocardiography, only 
the routine electrocardiogram was used for these compari-
sons. The results of cardiac catheterization were compared 
between the groups of patients with and without any pre-
mature ventricular complexes on routine electrocardiogram. 
Those with such complexes had a significantly higher right 
ventricular systolic pressure (57.8 ± 3.2 [mean ± SE] 
versus 47.0 ± 1. 1, P < O. ()() 1). In general, the higher the 
right ventricular systolic pressure, the greater the number 
of patients with premature ventricular complexes, the great-
est prevalence occurring with a right ventricular systolic 
pressure greater than 60 mm Hg (Fig. I). The right ven-
tricular end-diastolic pressure was also related, but less sig-
nificantly, to premature ventricular complexes. Such com-
plexes were found in 10.6% of those with a right ventricular 
end-diastolic pressure of 7 mm Hg or less compared with 
18.4% of those with an end-diastolic pressure of 8 mm Hg 
or more (p < 0.05). Since the right ventricular systolic and 
224 GARSON ET AL. 
PREVENTION OF SUDDEN DEATH IN TETRALOGY 
35 
30 
a: < < - 25 
..J ::; 
:l:I: 20 21-
a:>- 15 I-:I: 
za: 
wa: 10 >< 
iI 5 
0 
0-40 41-59 60-69 70-89 > 90 
PO RV SYSTOLIC PRESSURE (mmHg) 
Figure 1. Ventricular arrhythmias related to postoperative (PO) 
right ventricular (RV) systolic pressure. 
end-diastolic pressures are strongly related, the comparison 
was made of premature ventricular complexes in patients 
with a right ventricular systolic pressure less than 60 mm 
Hg. In this subgroup, if the right ventricular end-diastolic 
pressure was 8 mm Hg or more, 14% had premature ven-
tricular complexes compared with 8% of those with a lower 
end-diastolic pressure (p = 0.09). Therefore, there is a trend 
toward an independent effect on frequency of premature 
ventricular complexes if the right ventricular end-diastolic 
pressure is high when the right ventricular systolic pressure 
is low. Using the same analysis, when the right ventricular 
systolic pressure is high, the right ventricular end-diastolic 
pressure does not have an independent additive effect on 
premature ventricular complexes. 
Timing of surgery and follow-up. The presence of pre-
mature ventricular complexes was strongly related to the 
duration of follow-up. Patients with such complexes had a 
significantly longer follow-up (7.6 ± 0.7 years) than those 
without (5.8 ± 0.2 years) (p < 0.01). With increasing age 
at follow-up, there was a steadily increasing incidence of 
premature ventricular complexes; among patients 30 years 
of age and older, one-third had such complexes on routine 
electrocardiogram (Fig. 2). 
Age at the time of surgical repair was related to the 
presence of premature ventricular complexes (Fig. 3). With 
increasing patient age at repair, there was an increased in-
cidence of later development of premature ventricular com-
plexes. Further analysis, however, indicates that the dura-
tion of follow-up was probably the more significant factor, 
Figure 2. Ventricular arrhythmias related to age at follow-up. 
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Figure 3. Ventricular arrhythmias related to age at repair. 
since age at repair and duration of follow-up are significantly 
related. The major reason for this is that in recent years 
(with shorter follow-up time), the age of repair has de-
creased. For patients operated on before 2 years of age, the 
mean follow-up time is only 3.1 years. Since the average 
duration postoperatively of the development of premature 
ventricular complexes is 7 years, on the average these pa-
tients with early repair have not lived long enough to develop 
premature ventricular complexes. In addition, among those 
few patients operated on before 2 years of age who have 
been followed up for lO or more years, 50% have premature 
ventricular complexes. 
Factors predisposing to sudden death. Right ventric-
ular pressure. All the hemodynamic factors (right ventric-
ular systolic pressure, end-diastolic pressure and ventricular 
septal defect) that predispose to premature ventricular com-
plexes were also significantly higher in patients who later 
died suddenly than in those who did not. Of the nine patients 
who died suddenly, eight had undergone postoperative car-
diac catheterization. In six, the right ventricular systolic 
pressure was 60 mm Hg or more and the end-diastolic pres-
sure was 8 mm Hg or more. In two patients, only the end-
Figure 4. Comparison of aggressive antiarrhythmic treatment since 
1978 with previous years. The number of patients with ventricular 
arrhythmia (V.ARR) on routine electrocardiogram are compared 
with those treated (Rx) and those who died suddenly. Before 1978, 
few patients were treated and a significant number died. Since 
1978, the incidence of ventricular arrhythmias has increased but 
all patients have been treated. Only one patient died suddenly and 
he was thought to be noncompliant. 
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diastolic pressure increased. The age at repair was also 
significantly related to sudden death. Among those who died 
suddenly, only one (11 %) of nine had repair before 5 years 
of age compared with those who did not die suddenly, 
among whom 53% had repair before 5 years of age. Ad-
ditionally, seven of nine patients who died suddenly had 
the operation before 1974, when the routine use of cold 
cardioplegia during cardiopulmonary bypass was instituted. 
Ventricular arrhythmia. A major factor in sudden death 
was the presence of premature ventricular complexes on 
routine electrocardiogram. Each of the nine patients who 
died suddenly had premature ventricular complexes on rou-
tine electrocardiogram taken during a clinic visit before 
death. Among patients who did not die suddenly, premature 
ventricular complexes occurred in 12% (p < 0.0001). 
Role of antiarrhythmic treatment. In assessing the pre-
vention of sudden death, we compared the incidence of 
sudden death in patients who were and were not treated for 
premature ventricular complexes. Among patients who were 
not treated, 33% died suddenly compared with 4% of those 
who were treated with antiarrhythmic drugs (p < 0.0 I). 
There were no significant differences between those who 
received treatment and those who did not with respect to 
age at repair (7.5 ± 1.0 versus 9.4 ± 1.0 years, p = 0.52). 
However, if the stringent criteria are considered for docu-
mented control of ventricular arrhythmia on 24 hour elec-
trocardiogram, we have had no deaths among the 44 patients 
treated properly compared with 9 sudden deaths (39% mor-
tality rate) in the 23 patients who either were not treated or 
who did not have successful control (p < 0.001) (Table 2). 
From 1960 through 1977 before the aggressive treatment 
program began, there were eight sudden deaths and since 
1978 there has been only one in a patient who was being 
treated but who was probably noncompliant (Fig. 4). 
To assure that the treatment of patients since 1978 was 
a major factor in the reduction in sudden death, it is im-
portant to compare those who died suddenly with an ap-
propriate control group. We compared the 9 patients who 
died suddenly with the 44 patients with premature ventric-
ular complexes who are alive and receiving treatment. There 
was no difference in any variable including hemodynamic 
status, age at surgery or age at follow-up (Table 3). There-
fore, the only difference between those who died and those 
who are alive is that those who are alive were treated. 
Discussion 
Prevention of sudden death with antiarrhythmic 
drugs. Using an aggressive treatment program aimed at 
abolition of premature ventricular complexes from the rou-
tine and 24 hour electrocardiograms, we have demonstrated 
that sudden death after repair of tetralogy of Fallot can be 
markedly reduced. It has taken many years to demonstrate 
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Table 2. Sudden Death and Ventricular Arrhythmia in 488 
Postoperative Patients 
225 
Sudden Death Alive 
(no.) (no.) 
No. of ventricular arrhythmias 0 421 
Ventricular arrhythmias 
No treatment 7 14 
Treatment unsuccessful 2 0 
Treatment successful 0 44 
Total 9 479 
this effect because, fortunately, sudden deaths have been 
rare and usually occurred late after surgery. Therefore, it 
required a similar duration of follow-up in treated patients 
to be sure that it was the antiarrhythmic therapy that was 
causing the decrease in such deaths. 
The incidence of sudden death in untreated patients after 
repair of tetralogy of Fallot will now be difficult to deter-
mine. All the early reports (13,14) noted an incidence of 
sudden death of approximiltely 5%. However, because more 
recent reports have shown an increasing incidence of ven-
tricular arrhythmias with increasing duration of follow-up, 
it is likely that without treatment of these patients now, the 
incidence of late sudden death would be considerably higher 
than 5% in another 5 years of follow-up study. Therefore, 
it is possible that in 1985, had patients been left untreated, 
those who were 15 to 20 years postoperative might have an 
incidence of sudden death considerably higher than 5%. 
It is possible that the implantation of a pacemaker in 
some of our patients may also have contributed to the re-
duction in late death. However, the number of these patients 
is small compared with that of patients with ventricular 
arrhythmias. It is difficult to determine the contribution of 
more modem surgical techniques, such as the use of car-
dioplegia, to prevention of sudden death. In our series, as 
well as others (14), patients who had cardiopulmonary by-
pass with cardioplegia have later died suddenly. 
Drug treatment protocol. Compared with adult studies 
(IS, 16) on ventricular arrhythmias and sudden deaths, the 
ventricular arrhythmias in our patients were rather easily 
controlled. Our patients required only 1.4 drugs per patient 
for control compared with 4 to 5 drugs per patient in many 
adult studies (15,16). In addition, the spectrum of drugs 
that are effective in our patients is quite different from that 
in adults. Phenytoin and mexiletine in adults are not rec-
ognized as the best primary antiarrhythmic drugs, whereas 
in our patients they were effective in 85 to 90%. Propran-
olol, also not a traditional primary agent for ventricular 
arrhythmias in adults, was relatively effective in the post-
operative patients with tetralogy to whom it was given (that 
is, only those with good ventricular function). Quinidine, 
traditionally a widely used ventricular antiarrhythmic agent 
in adults, was relatively unsuccessful in our patients. Fi-
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Table 3. Fifty-three Patients With Premature Ventricular Complexes: Correlation With 
Other Factors 
Sudden Death Treated and Alive 
(no. = 9)* (no. = 44)* P Value 
Postop RVSP (mm Hg) 66.5 ± 7.7 60.3 ± 4.6 0.50 (NS) 
Postop RVEDP (mm Hg) 8.9 ± 1.0 7.3 ± 0.8 0.32 (NS) 
Age at repair (yr) 10.2 ± 1.1 7.5 ± 1.0 0.16 (NS) 
Follow-up duration (yr) 5.2 ± 1.7 8.0 ± 4.8 0.17 (NS) 
Age at last follow-up (yr) 15.5 ± 2.0 14.7 ± 1.3 0.76 (NS) 
*For those undergoing cardiac catheterization. no. = 8 for sudden death group and no. = 28 for treated 
group. NS = no statistical difference; p = probability; postop = postoperative; RVEDP = right ventricular 
end-diastolic pressure; RVSP = right ventricular systolic pressure. 
nally, amiodarone therapy seems to be as successful in chil-
dren as it is in adults. The reason for the differences in ease 
of control and type of drugs that achieve control are not 
known at present. It is possible that in adults with coronary 
artery disease, intermittent ischemia may alter the blood 
supply to certain arrhythmogenic areas causing electro-
physiologic changes in the tissue and reducing the amount 
of antiarrhythmic drug delivered to that tissue. It is also 
possible that the cellular mechanisms for ventricular ar-
rhythmias are different in patients after repair of tetralogy 
of Fallot than in those with coronary artery disease. This is 
under active investigation in our experimental laboratory 
(17). 
Criteria for drug treatment. Fortunately, the long-term 
side effects of drug treatment in our patients have been 
minimal, and actually less than those found in adults. It is 
clear that, using our recommendations for treatment of even 
frequent uniform premature ventricular complexes on 24 
hour electrocardiogram, we are overtreating a certain group 
of our patients. It would, indeed, be desirable to develop 
stricter criteria for treatment of ventricular arrhythmias. We 
(18) and others (19,20) have performed ventricular extra-
stimulus protocols on such patients in an attempt to identify 
those who require treatment. At present, the clinical im-
plications of inducibility of ventricular arrhythmias are un-
certain, since even sustained ventricular tachycardia has 
been induced in asymptomatic patients with no ventricular 
arrhythmia on Holter monitor (19). 
Ideally, a randomized placebo-controlled prospective study 
should be undertaken to determine which arrhythmias need 
treatment. This is, in a sense, being done, since at present 
there are numerous treatment strategies around the world. 
Through the auspices of the Pediatric Electrophysiology 
Society, we plan to review our results periodically. With 
the psychological and economic burdens imposed by long-
term drug therapy, it would be desirable to develop a more 
direct approach to the prevention of sudden death. 
Primary prevention of sudden death. Since it appears 
that the majority of sudden deaths are related to ventricular 
arrhythmias, the question arises as to whether ventricular 
arrhythmias can be prevented primarily. There is a statistical 
relation between right ventricular systolic pressure and ven-
tricular arrhythmias, but this is clearly not the entire answer 
since 10% of patients with a low pressure have ventricular 
arrhythmias and 70% of those with a high pressure do not. 
Nonetheless, it might be that if the hemodynamic results 
could be improved, the incidence of ventricular arrhythmias 
might decrease. In certain cases it is not possible to reduce 
the right ventricular outflow obstruction any further because 
of small distal pulmonary arteries. However, there are in-
creasing numbers of reports (13,14) linking ventricular ar-
rhythmias to abnormal right ventricular function (which we 
could not examine in this retrospective review). This is 
likely to be related to pulmonary insufficiency. From our 
study and others, we know that the incidence of ventricular 
arrhythmias increases with the increase in duration of fol-
low-up. We know that right ventricular dysfunction may 
develop over time and it may be this dysfunction with its 
attendant stretch in areas adjacent to the ventriculotomy that 
may provide the basis for the development of late ventricular 
arrhythmias. In the future, primary prevention of ventricular 
arrhythmias will likely be directed toward I) production of 
as small an area of ventriculotomy and outflow resection as 
possible to give a small scar, 2) reduction of the right ven-
tricular systolic pressure, and 3) insertion of some device 
(monocusp, valve or otherwise) that will prevent pulmonary 
regurgitation. Although a step has been made in the pre-
vention of sudden death, if we could prevent the conditions 
for development of ventricular arrhythmias these children 
could be permitted to lead an active life without the need 
for drugs. 
Conclusions. The majority of sudden deaths after repair 
of tetralogy of Fallot are due to ventricular arrhythmias that 
occur in the setting of abnormal hemodynamics and in-
creasing time after surgery. With aggressive use of antiar-
rhythmic drugs and adequate control of ventricular arrhyth-
mia, the incidence of sudden death can be significantly 
reduced. 
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